Stay updated on Pembrolizumab/Gemcitabine in ABC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab/Gemcitabine in ABC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab/Gemcitabine in ABC Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.5.3 to v3.5.4, indicating a new internal version of the page.
    Difference
    0.0%
    Check dated 2026-05-15T05:34:45.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The study record revision was updated to v3.5.3, replacing the previous v3.5.2 revision, indicating a small metadata update to the entry.
    Difference
    0.0%
    Check dated 2026-04-30T18:18:06.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.2, replacing Revision: v3.5.0; no visible changes to content or features.
    Difference
    0.0%
    Check dated 2026-04-16T11:52:04.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0. No study details or user-facing content appear to be affected.
    Difference
    0.0%
    Check dated 2026-03-18T21:58:27.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-11T19:57:52.000Z thumbnail image
  8. Check
    103 days ago
    Change Detected
    Summary
    A new site revision 'Revision: v3.4.2' has been added and the previous 'Revision: v3.4.1' notice removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T09:17:25.000Z thumbnail image

Stay in the know with updates to Pembrolizumab/Gemcitabine in ABC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab/Gemcitabine in ABC Clinical Trial page.